Keyword: False Claims Act

Bristol-Myers Squibb tried and failed to escape a lawsuit claiming it miscalculated average drug prices to underpay Medicaid rebates for years.

Whistleblowers alleging Lilly ran a "multi-tiered kickback scheme" will have to rework their complaint after a judge tossed the case.

Gilead hit with revived lawsuit claiming it sourced a key HIV drug ingredient from an unapproved Chinese manufacturer.

A new FDA rule that would govern off-label marketing has drugmakers in a minor tizzy—and they're demanding that the agency set its change aside.